Copyright Reports & Markets. All rights reserved.

Global Buprenorphine Transdermal Patches Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

Request for Sample of this report
Buy now

1 Market Overview

  • 1.1 Product Overview and Scope of Buprenorphine Transdermal Patches
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Buprenorphine Transdermal Patches Consumption Value by Type: 2019 Versus 2023 Versus 2030
    • 1.3.2 5mcg/h
    • 1.3.3 7.5mcg/h
    • 1.3.4 10mcg/h
    • 1.3.5 15 mcg/h
    • 1.3.6 20 mcg/h
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global Buprenorphine Transdermal Patches Consumption Value by Application: 2019 Versus 2023 Versus 2030
    • 1.4.2 Relieve Cancer Pain
    • 1.4.3 Other
  • 1.5 Global Buprenorphine Transdermal Patches Market Size & Forecast
    • 1.5.1 Global Buprenorphine Transdermal Patches Consumption Value (2019 & 2023 & 2030)
    • 1.5.2 Global Buprenorphine Transdermal Patches Sales Quantity (2019-2030)
    • 1.5.3 Global Buprenorphine Transdermal Patches Average Price (2019-2030)

2 Manufacturers Profiles

  • 2.1 Grunenthal
    • 2.1.1 Grunenthal Details
    • 2.1.2 Grunenthal Major Business
    • 2.1.3 Grunenthal Buprenorphine Transdermal Patches Product and Services
    • 2.1.4 Grunenthal Buprenorphine Transdermal Patches Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.1.5 Grunenthal Recent Developments/Updates
  • 2.2 PurduePharma
    • 2.2.1 PurduePharma Details
    • 2.2.2 PurduePharma Major Business
    • 2.2.3 PurduePharma Buprenorphine Transdermal Patches Product and Services
    • 2.2.4 PurduePharma Buprenorphine Transdermal Patches Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.2.5 PurduePharma Recent Developments/Updates
  • 2.3 Luye Pharma
    • 2.3.1 Luye Pharma Details
    • 2.3.2 Luye Pharma Major Business
    • 2.3.3 Luye Pharma Buprenorphine Transdermal Patches Product and Services
    • 2.3.4 Luye Pharma Buprenorphine Transdermal Patches Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.3.5 Luye Pharma Recent Developments/Updates

3 Competitive Environment: Buprenorphine Transdermal Patches by Manufacturer

  • 3.1 Global Buprenorphine Transdermal Patches Sales Quantity by Manufacturer (2019-2024)
  • 3.2 Global Buprenorphine Transdermal Patches Revenue by Manufacturer (2019-2024)
  • 3.3 Global Buprenorphine Transdermal Patches Average Price by Manufacturer (2019-2024)
  • 3.4 Market Share Analysis (2023)
    • 3.4.1 Producer Shipments of Buprenorphine Transdermal Patches by Manufacturer Revenue ($MM) and Market Share (%): 2023
    • 3.4.2 Top 3 Buprenorphine Transdermal Patches Manufacturer Market Share in 2023
    • 3.4.2 Top 6 Buprenorphine Transdermal Patches Manufacturer Market Share in 2023
  • 3.5 Buprenorphine Transdermal Patches Market: Overall Company Footprint Analysis
    • 3.5.1 Buprenorphine Transdermal Patches Market: Region Footprint
    • 3.5.2 Buprenorphine Transdermal Patches Market: Company Product Type Footprint
    • 3.5.3 Buprenorphine Transdermal Patches Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Buprenorphine Transdermal Patches Market Size by Region
    • 4.1.1 Global Buprenorphine Transdermal Patches Sales Quantity by Region (2019-2030)
    • 4.1.2 Global Buprenorphine Transdermal Patches Consumption Value by Region (2019-2030)
    • 4.1.3 Global Buprenorphine Transdermal Patches Average Price by Region (2019-2030)
  • 4.2 North America Buprenorphine Transdermal Patches Consumption Value (2019-2030)
  • 4.3 Europe Buprenorphine Transdermal Patches Consumption Value (2019-2030)
  • 4.4 Asia-Pacific Buprenorphine Transdermal Patches Consumption Value (2019-2030)
  • 4.5 South America Buprenorphine Transdermal Patches Consumption Value (2019-2030)
  • 4.6 Middle East and Africa Buprenorphine Transdermal Patches Consumption Value (2019-2030)

5 Market Segment by Type

  • 5.1 Global Buprenorphine Transdermal Patches Sales Quantity by Type (2019-2030)
  • 5.2 Global Buprenorphine Transdermal Patches Consumption Value by Type (2019-2030)
  • 5.3 Global Buprenorphine Transdermal Patches Average Price by Type (2019-2030)

6 Market Segment by Application

  • 6.1 Global Buprenorphine Transdermal Patches Sales Quantity by Application (2019-2030)
  • 6.2 Global Buprenorphine Transdermal Patches Consumption Value by Application (2019-2030)
  • 6.3 Global Buprenorphine Transdermal Patches Average Price by Application (2019-2030)

7 North America

  • 7.1 North America Buprenorphine Transdermal Patches Sales Quantity by Type (2019-2030)
  • 7.2 North America Buprenorphine Transdermal Patches Sales Quantity by Application (2019-2030)
  • 7.3 North America Buprenorphine Transdermal Patches Market Size by Country
    • 7.3.1 North America Buprenorphine Transdermal Patches Sales Quantity by Country (2019-2030)
    • 7.3.2 North America Buprenorphine Transdermal Patches Consumption Value by Country (2019-2030)
    • 7.3.3 United States Market Size and Forecast (2019-2030)
    • 7.3.4 Canada Market Size and Forecast (2019-2030)
    • 7.3.5 Mexico Market Size and Forecast (2019-2030)

8 Europe

  • 8.1 Europe Buprenorphine Transdermal Patches Sales Quantity by Type (2019-2030)
  • 8.2 Europe Buprenorphine Transdermal Patches Sales Quantity by Application (2019-2030)
  • 8.3 Europe Buprenorphine Transdermal Patches Market Size by Country
    • 8.3.1 Europe Buprenorphine Transdermal Patches Sales Quantity by Country (2019-2030)
    • 8.3.2 Europe Buprenorphine Transdermal Patches Consumption Value by Country (2019-2030)
    • 8.3.3 Germany Market Size and Forecast (2019-2030)
    • 8.3.4 France Market Size and Forecast (2019-2030)
    • 8.3.5 United Kingdom Market Size and Forecast (2019-2030)
    • 8.3.6 Russia Market Size and Forecast (2019-2030)
    • 8.3.7 Italy Market Size and Forecast (2019-2030)

9 Asia-Pacific

  • 9.1 Asia-Pacific Buprenorphine Transdermal Patches Sales Quantity by Type (2019-2030)
  • 9.2 Asia-Pacific Buprenorphine Transdermal Patches Sales Quantity by Application (2019-2030)
  • 9.3 Asia-Pacific Buprenorphine Transdermal Patches Market Size by Region
    • 9.3.1 Asia-Pacific Buprenorphine Transdermal Patches Sales Quantity by Region (2019-2030)
    • 9.3.2 Asia-Pacific Buprenorphine Transdermal Patches Consumption Value by Region (2019-2030)
    • 9.3.3 China Market Size and Forecast (2019-2030)
    • 9.3.4 Japan Market Size and Forecast (2019-2030)
    • 9.3.5 Korea Market Size and Forecast (2019-2030)
    • 9.3.6 India Market Size and Forecast (2019-2030)
    • 9.3.7 Southeast Asia Market Size and Forecast (2019-2030)
    • 9.3.8 Australia Market Size and Forecast (2019-2030)

10 South America

  • 10.1 South America Buprenorphine Transdermal Patches Sales Quantity by Type (2019-2030)
  • 10.2 South America Buprenorphine Transdermal Patches Sales Quantity by Application (2019-2030)
  • 10.3 South America Buprenorphine Transdermal Patches Market Size by Country
    • 10.3.1 South America Buprenorphine Transdermal Patches Sales Quantity by Country (2019-2030)
    • 10.3.2 South America Buprenorphine Transdermal Patches Consumption Value by Country (2019-2030)
    • 10.3.3 Brazil Market Size and Forecast (2019-2030)
    • 10.3.4 Argentina Market Size and Forecast (2019-2030)

11 Middle East & Africa

  • 11.1 Middle East & Africa Buprenorphine Transdermal Patches Sales Quantity by Type (2019-2030)
  • 11.2 Middle East & Africa Buprenorphine Transdermal Patches Sales Quantity by Application (2019-2030)
  • 11.3 Middle East & Africa Buprenorphine Transdermal Patches Market Size by Country
    • 11.3.1 Middle East & Africa Buprenorphine Transdermal Patches Sales Quantity by Country (2019-2030)
    • 11.3.2 Middle East & Africa Buprenorphine Transdermal Patches Consumption Value by Country (2019-2030)
    • 11.3.3 Turkey Market Size and Forecast (2019-2030)
    • 11.3.4 Egypt Market Size and Forecast (2019-2030)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2019-2030)
    • 11.3.6 South Africa Market Size and Forecast (2019-2030)

12 Market Dynamics

  • 12.1 Buprenorphine Transdermal Patches Market Drivers
  • 12.2 Buprenorphine Transdermal Patches Market Restraints
  • 12.3 Buprenorphine Transdermal Patches Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Buprenorphine Transdermal Patches and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Buprenorphine Transdermal Patches
  • 13.3 Buprenorphine Transdermal Patches Production Process
  • 13.4 Buprenorphine Transdermal Patches Industrial Chain

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Buprenorphine Transdermal Patches Typical Distributors
  • 14.3 Buprenorphine Transdermal Patches Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    According to our (Global Info Research) latest study, the global Buprenorphine Transdermal Patches market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.
    The Global Info Research report includes an overview of the development of the Buprenorphine Transdermal Patches industry chain, the market status of Relieve Cancer Pain (5mcg/h, 7.5mcg/h), Other (5mcg/h, 7.5mcg/h), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Buprenorphine Transdermal Patches.
    Regionally, the report analyzes the Buprenorphine Transdermal Patches markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Buprenorphine Transdermal Patches market, with robust domestic demand, supportive policies, and a strong manufacturing base.
    Key Features:
    The report presents comprehensive understanding of the Buprenorphine Transdermal Patches market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Buprenorphine Transdermal Patches industry.
    The report involves analyzing the market at a macro level:
    Market Sizing and Segmentation: Report collect data on the overall market size, including the sales quantity (K Units), revenue generated, and market share of different by Type (e.g., 5mcg/h, 7.5mcg/h).
    Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Buprenorphine Transdermal Patches market.
    Regional Analysis: The report involves examining the Buprenorphine Transdermal Patches market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
    Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Buprenorphine Transdermal Patches market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
    The report also involves a more granular approach to Buprenorphine Transdermal Patches:
    Company Analysis: Report covers individual Buprenorphine Transdermal Patches manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
    Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Buprenorphine Transdermal Patches This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Relieve Cancer Pain, Other).
    Technology Analysis: Report covers specific technologies relevant to Buprenorphine Transdermal Patches. It assesses the current state, advancements, and potential future developments in Buprenorphine Transdermal Patches areas.
    Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Buprenorphine Transdermal Patches market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
    Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
    Market Segmentation
    Buprenorphine Transdermal Patches market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
    Market segment by Type
    5mcg/h
    7.5mcg/h
    10mcg/h
    15 mcg/h
    20 mcg/h
    Market segment by Application
    Relieve Cancer Pain
    Other
    Major players covered
    Grunenthal
    PurduePharma
    Luye Pharma
    Market segment by region, regional analysis covers
    North America (United States, Canada and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 15 chapters:
    Chapter 1, to describe Buprenorphine Transdermal Patches product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top manufacturers of Buprenorphine Transdermal Patches, with price, sales, revenue and global market share of Buprenorphine Transdermal Patches from 2019 to 2024.
    Chapter 3, the Buprenorphine Transdermal Patches competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
    Chapter 4, the Buprenorphine Transdermal Patches breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2019 to 2030.
    Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2019 to 2030.
    Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2023.and Buprenorphine Transdermal Patches market forecast, by regions, type and application, with sales and revenue, from 2025 to 2030.
    Chapter 12, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
    Chapter 13, the key raw materials and key suppliers, and industry chain of Buprenorphine Transdermal Patches.
    Chapter 14 and 15, to describe Buprenorphine Transdermal Patches sales channel, distributors, customers, research findings and conclusion.

    Buy now